FTSE 100 news / Companies and sectors / Smith & Nephew / 7 October 2026
Smith & Nephew (SN): news on Wednesday 7 October 2026
+7.5 strongly positive
Coverage was mainly about the European launch of the Cartiheal Agili-C cartilage repair implant, which reads as a positive product development. There was also minor attention on a note redemption notice and the share price ahead of results.
What drove it
- Cartiheal Agili-C European launch
- note redemption notice
- upcoming results
The 7 stories
- +9.2 Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal
European launch of cartilage repair implant is a positive product milestone. - +8.3 Smith & Nephew launches knee cartilage repair implant in Europe
Knee cartilage implant launch in Europe supports growth prospects. - +8.3 Smith & Nephew Launches Cartiheal Agili-C Implant Across Europe, Ticker SNN Updates
Europe-wide launch of Agili-C implant, a positive product story. - +8.0 Smith+Nephew lanza en Europa el innovador implante de reparación de cartílago CARTIHEAL™ AGILI-C™, que será protagonista en el Congreso ICRS de Portugal
Spanish version of the positive European implant launch. - +8.0 Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l’innovativo impianto per la riparazione della cartilagine, che sarà presentato all’ICRS Summit in Portogallo.
Italian version of the positive European implant launch. - +1.7 Smith & Nephew stock costs EUR 12.15 ahead of results
Share price quote ahead of results; largely factual. - +0.8 Why Is Smith & Nephew (LSE:SN.) Stock In Focus This Week After Its Note Redemption Notice?
Note redemption notice is a routine financing matter, mostly neutral.
Smith & Nephew: every day · Pharma and healthcare on 7 October 2026 · FTSE 100 overview for the day